Serum superoxide dismutase (SOD) and catalase (CAT) activities were greater in the NAFLD group than in controls (p < 0.01), but the differences between NAFL and NASH patients were not statistically significant (p = 0.081). Here, SOD1 is linked to metabolic dysfunction-associated steatotic liver disease.